Sat.Dec 31, 2022 - Fri.Jan 06, 2023

article thumbnail

Agility to Fight a Recession: Emerging Biopharma’s Secret Weapon

Zymewire

Agility to Fight a Recession: Emerging Biopharma’s Secret Weapon. Zymewire News

article thumbnail

Pfizer, GSK, AbbVie and many more celebrate New Year with price hikes: report

Fierce Pharma

Pfizer, GSK, AbbVie and many more celebrate New Year with price hikes: report. esagonowsky. Wed, 01/04/2023 - 10:21

Pharma 299
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Google and DeepMind share work on medical chatbot Med-PaLM

pharmaphorum

Google and DeepMind have developed an artificial intelligence-powered chatbot tool called Med-PaLM designed to generate “safe and helpful answers” to questions posed by healthcare professionals and patients.

Medical 136
article thumbnail

Technology as a New Evolution in Fighting Disease

PharmaTech

Advancing the use of AI to understand the whole of a disease can reveal drug development insights that lead to drug discovery breakthroughs.

Leads 122
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

This webinar will go over the FDA's guidance on pharmacological and toxicological considerations for optimizing doses for prescription drugs.

article thumbnail

Point-Of-Care Biosensor to Detect Oral Cancer

Medgadget

Researchers at the University of Florida have created a point-of-care biosensor that can rapidly detect a biomarker for oral cancer.

Medical 116

More Trending

article thumbnail

UK partners with BioNTech on clinical trials of mRNA cancer therapies

pharmaphorum

The UK has formed an partnership with German biotech BioNTech to provide up to 10,000 patients with access to personalised cancer therapies, in another example of the country embracing the mRNA technologies that underpinned COVID-19 vaccines.

article thumbnail

Forks in the road lead one medical expert to a ‘game changing’ liver treatment

PharmaVoice

Durect’s chief medical officer altered his retirement plans to take a leading role at the company, which is developing a treatment for severe alcohol-associated hepatitis

Leads 111
article thumbnail

Bioprinted Eye Tissue to Study Retinal Diseases

Medgadget

Researchers at the National Eye Institute, which is part of the National Institutes of Health, have created a method to 3D bioprint eye tissue that forms the outer blood-retina barrier.

Ethics 112
article thumbnail

Moderna makes its first-ever acquisition, buying Japanese DNA manufacturer OriCiro for $85M

Fierce Pharma

Moderna makes its first-ever acquisition, buying Japanese DNA manufacturer OriCiro for $85M. mbayer. Wed, 01/04/2023 - 06:37

article thumbnail

6 research and development life sciences predictions for 2023

pharmaphorum

From enabling patient choice during clinical trials to strengthening vital partnerships across the quality ecosystem, connected data will become the lifeblood that enables life sciences teams to collaborate efficiently and effectively in 2023.

Safety 111
article thumbnail

The Growth and Emergence of Technology in the Outsourcing Space

PharmaTech

CMOs are hoping to grow outsourcing to significantly higher levels in many different areas, with a focus on analytical testing, toxicity testing, and fill/finish operations.

111
111
article thumbnail

Four Vital Optimizations Required For Digital Marketing Success

Healthcare Success

I’ve noticed that most people tend to focus on only one of four variables when optimizing their digital marketing results. That’s a shame because true optimization requires a more strategic approach that considers each of the following four factors: Consumer Demand. Campaign Management (e.g.,

Marketing 111
article thumbnail

Novartis pays $245M to settle Exforge generic pay-for-delay lawsuit

Fierce Pharma

Novartis pays $245M to settle Exforge generic pay-for-delay lawsuit. Tue, 01/03/2023 - 10:59

Pharma 240
article thumbnail

Type 1 Diabetes: A Potential Cure

PharmExec

One company pursues a program for a technology they believe is a potential cure for Type 1 diabetes.

105
105
article thumbnail

Why script-to-dispense conversion will take centre stage in 2023

pharmaphorum

With the US economy teetering on a recession, sales and marketing budgets are expected to take a hit among businesses across sectors. The pharmaceutical industry is no exception.

article thumbnail

Inhalation Vaccine Development

PharmaTech

Inhaled vaccines must resist degradation and penetrate the mucosal lining in the airways and lungs.

105
105
article thumbnail

Particulates, label issues prompt separate recalls for Pfizer's Hospira and Accord

Fierce Pharma

Particulates, label issues prompt separate recalls for Pfizer's Hospira and Accord. zbecker. Wed, 01/04/2023 - 11:35

Pharma 238
article thumbnail

Q&A with Kelly Baker, CFO of Eversana

PharmExec

Baker spoke on topics ranging from pricing, access, the war for talent, and other key areas that are impacting pharma companies.

Pharma 105
article thumbnail

It’s time for more tech and biotech innovation in 2023

pharmaphorum

The drive to make the UK a ‘scientific powerhouse’ was central to the government’s announcement closing out 2022 , which appointed five industry experts to lead on the sectors most vital to UK’s future innovation.

article thumbnail

Nonprofits are bridging R&D’s valley of death

PharmaVoice

How charitable firms such as Advancium are helping to right the market wrongs of drug development

Marketing 102
article thumbnail

With Leqembi approval in Alzheimer's disease, Eisai and Biogen plot 'meticulous' launch

Fierce Pharma

With Leqembi approval in Alzheimer's disease, Eisai and Biogen plot 'meticulous' launch. fkansteiner. Fri, 01/06/2023 - 12:44

Pharma 235
article thumbnail

State of Financing Deals and Go-to-Market Strategy in Biotech: Q&A with Timothy Moore and Jack Mycka, Indegene

PharmExec

A chat with with Indegene's Timothy Moore, Senior Vice President, Emerging Biotech and Key Accounts and Jack Mycka, Vice President, Enterprise Medical Solutions and Emerging Biotech.

Medical 98
article thumbnail

Newron says pivotal treatment-resistant schizophrenia trial is a go

pharmaphorum

Encouraged by new data, Newron Pharmaceuticals has said it will start a registration study of would-be blockbuster evenamide in treatment-resistant schizophrenia (TRS) later this year.

article thumbnail

How To Run Outstanding Marketing Events for Senior Living Communities

Clear Pivot

Warmth, hospitality, and friendliness are all crucial for senior living communities. In fact, your success as a business depends on it.

article thumbnail

Lilly, Merck double down on peptide-targeted drug delivery, betting billions in biobucks on PeptiDream pacts

Fierce Pharma

Lilly, Merck double down on peptide-targeted drug delivery, betting billions in biobucks on PeptiDream pacts. ntaylor. Tue, 01/03/2023 - 08:31

Pharma 235
article thumbnail

How Market Access Can Determine Commercial Success

PharmExec

Using market access data from day one of your drug development and commercialization journey puts your brand in the best position to succeed at launch.

article thumbnail

The end-of-life care conundrum

pharmaphorum

Research advises against aggressive cancer treatment at the end-of-life stages of the disease. At the same time, the pharmaceutical industry is creating a greater number of oncology treatments that could provide breakthroughs for patients where none previously existed.

article thumbnail

Lilly, Biogen, Eisai brace for Alzheimer’s boom or bust in 2023

PharmaVoice

As controversies abound and new drugs rise on the regulatory horizon, this year will be big for Alzheimer’s

98
article thumbnail

Unicycive's pivotal trial of rival to Takeda kidney drug hits main goal, clearing path to FDA filing

Fierce Pharma

Unicycive's pivotal trial of rival to Takeda kidney drug hits main goal, clearing path to FDA filing. ntaylor. Tue, 01/03/2023 - 03:20

FDA 228
article thumbnail

FDA Policy Change Heightens Debate Over Medicated Abortion

PharmaTech

The agency revised a regulation to enable pharmacies to dispense mifepristone directly to individuals with a prescription.

article thumbnail

How decentralised storage networks can change the game for the pharmaceutical industry

pharmaphorum

The way pharmaceutical companies manage data carries inherent risks, as exemplified by the constant scandals about data breaches. Is there anything that can be done about this?

article thumbnail

A new mission in menopause — extending the lives of women

PharmaVoice

Why Evernow CEO Alicia Jackson thinks menopause is the perfect inroad to helping women live longer lives

98
article thumbnail

Pfizer picks up steam in its pursuit of Merck's next-gen pneumococcal vaccine

Fierce Pharma

Pfizer picks up steam in its pursuit of Merck's next-gen pneumococcal vaccine. kdunleavy. Fri, 01/06/2023 - 09:49

Pharma 222